Cargando…

Efficient Feeder-Free Episomal Reprogramming with Small Molecules

Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises, human iPSCs will ideally be free of exogenous DNA (footprint-free), and be derived and cultured in chemically define...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Junying, Chau, Kevin Fongching, Vodyanik, Maxim A., Jiang, Jinlan, Jiang, Yong
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046978/
https://www.ncbi.nlm.nih.gov/pubmed/21390254
http://dx.doi.org/10.1371/journal.pone.0017557
_version_ 1782199010004566016
author Yu, Junying
Chau, Kevin Fongching
Vodyanik, Maxim A.
Jiang, Jinlan
Jiang, Yong
author_facet Yu, Junying
Chau, Kevin Fongching
Vodyanik, Maxim A.
Jiang, Jinlan
Jiang, Yong
author_sort Yu, Junying
collection PubMed
description Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises, human iPSCs will ideally be free of exogenous DNA (footprint-free), and be derived and cultured in chemically defined media free of feeder cells. Currently, methods are available to enable efficient derivation of footprint-free human iPSCs. However, each of these methods has its limitations. We have previously derived footprint-free human iPSCs by employing episomal vectors for transgene delivery, but the process was inefficient and required feeder cells. Here, we have greatly improved the episomal reprogramming efficiency using a cocktail containing MEK inhibitor PD0325901, GSK3β inhibitor CHIR99021, TGF-β/Activin/Nodal receptor inhibitor A-83-01, ROCK inhibitor HA-100 and human leukemia inhibitory factor. Moreover, we have successfully established a feeder-free reprogramming condition using chemically defined medium with bFGF and N2B27 supplements and chemically defined human ESC medium mTeSR1 for the derivation of footprint-free human iPSCs. These improvements enabled the routine derivation of footprint-free human iPSCs from skin fibroblasts, adipose tissue-derived cells and cord blood cells. This technology will likely be valuable for the production of clinical-grade human iPSCs.
format Text
id pubmed-3046978
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30469782011-03-09 Efficient Feeder-Free Episomal Reprogramming with Small Molecules Yu, Junying Chau, Kevin Fongching Vodyanik, Maxim A. Jiang, Jinlan Jiang, Yong PLoS One Research Article Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises, human iPSCs will ideally be free of exogenous DNA (footprint-free), and be derived and cultured in chemically defined media free of feeder cells. Currently, methods are available to enable efficient derivation of footprint-free human iPSCs. However, each of these methods has its limitations. We have previously derived footprint-free human iPSCs by employing episomal vectors for transgene delivery, but the process was inefficient and required feeder cells. Here, we have greatly improved the episomal reprogramming efficiency using a cocktail containing MEK inhibitor PD0325901, GSK3β inhibitor CHIR99021, TGF-β/Activin/Nodal receptor inhibitor A-83-01, ROCK inhibitor HA-100 and human leukemia inhibitory factor. Moreover, we have successfully established a feeder-free reprogramming condition using chemically defined medium with bFGF and N2B27 supplements and chemically defined human ESC medium mTeSR1 for the derivation of footprint-free human iPSCs. These improvements enabled the routine derivation of footprint-free human iPSCs from skin fibroblasts, adipose tissue-derived cells and cord blood cells. This technology will likely be valuable for the production of clinical-grade human iPSCs. Public Library of Science 2011-03-01 /pmc/articles/PMC3046978/ /pubmed/21390254 http://dx.doi.org/10.1371/journal.pone.0017557 Text en Yu et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Yu, Junying
Chau, Kevin Fongching
Vodyanik, Maxim A.
Jiang, Jinlan
Jiang, Yong
Efficient Feeder-Free Episomal Reprogramming with Small Molecules
title Efficient Feeder-Free Episomal Reprogramming with Small Molecules
title_full Efficient Feeder-Free Episomal Reprogramming with Small Molecules
title_fullStr Efficient Feeder-Free Episomal Reprogramming with Small Molecules
title_full_unstemmed Efficient Feeder-Free Episomal Reprogramming with Small Molecules
title_short Efficient Feeder-Free Episomal Reprogramming with Small Molecules
title_sort efficient feeder-free episomal reprogramming with small molecules
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046978/
https://www.ncbi.nlm.nih.gov/pubmed/21390254
http://dx.doi.org/10.1371/journal.pone.0017557
work_keys_str_mv AT yujunying efficientfeederfreeepisomalreprogrammingwithsmallmolecules
AT chaukevinfongching efficientfeederfreeepisomalreprogrammingwithsmallmolecules
AT vodyanikmaxima efficientfeederfreeepisomalreprogrammingwithsmallmolecules
AT jiangjinlan efficientfeederfreeepisomalreprogrammingwithsmallmolecules
AT jiangyong efficientfeederfreeepisomalreprogrammingwithsmallmolecules